Skip Navigation

Badger-founded Constantiam Biosciences secures $2M from the NIH

Constantiam Biosciences is a biotechnology start-up company founded by three Wisconsin grads — Nicholas Schafer ’08, Daniel Goldman ’07, and Norman Ong ’07 — focused on interpreting the vast diversity of human genetic variation to improve outcomes for patients afflicted by cancer, neurodegeneration, and cardiovascular disease. The company has been awarded a $2M Small Business Innovation Research (SBIR) grant from the National Human Genome Research Institute (NHGRI) to develop technologies aimed at addressing medically inactionable variants of uncertain significance (VUS) uncovered in clinical genetic tests. Constantiam’s technologies enable classification of VUS to improve patient outcomes across a wide variety of medical conditions, unlocking the power of precision medicine.

More Alumni Notes

William Mark Caplan, beloved husband, father, brother, and uncle. Anchored his family with gentle wisdom, deep compassion, and infinite generosity. Lived a life of mitzvot. Proud graduate of the University of Wisconsin and the Washington Universit...

Three cheers — or U-Rah-Rahs — to each and every WAA member! Happy Member Appreciation Month and thanks to those of you who are a part of this Badger community. Please enjoy special perks all April long. Not a member? Join today.